Company Filing History:
Years Active: 2011-2017
Title: The Innovative Contributions of Olivia Raeber
Introduction
Olivia Raeber is a prominent inventor based in Redwood City, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of binding proteins specific for insulin-like growth factors. With a total of 4 patents to her name, Raeber's work has the potential to impact various medical applications.
Latest Patents
One of Raeber's latest patents focuses on binding proteins, such as antibodies directed to IGF-II with cross-reactivity to IGF-I. This patent describes fully human monoclonal antibodies that target IGF-II while also being reactive to IGF-I. Additionally, the patent discusses nucleotide sequences encoding and amino acid sequences comprising heavy and light chain immunoglobulin molecules. These sequences are particularly relevant to the framework regions and complementarity determining regions (CDRs), specifically from FR1 through FR4 or CDR1 through CDR3.
Career Highlights
Olivia Raeber is currently associated with Medimmune Limited, where she continues to advance her research and innovations. Her work has garnered attention for its potential applications in therapeutic settings, particularly in the treatment of conditions related to insulin-like growth factors.
Collaborations
Raeber has collaborated with notable colleagues, including Gadi Gazit-Bornstein and Susan Ann Cartlidge. These partnerships have contributed to the success of her research and the development of her patents.
Conclusion
Olivia Raeber's innovative work in the field of biotechnology exemplifies the impact of dedicated inventors on medical science. Her contributions, particularly in the area of binding proteins, highlight the importance of research and collaboration in advancing healthcare solutions.